Location History:
- Frontingnan, FR (2019)
- Frontignan, FR (2023)
Company Filing History:
2 out of 38 
2 out of 5,081 
2 out of 154 
Years Active: 2019-2023
Title: Karim Chebli: Innovator in Inflammatory Disease Treatment
Introduction
Karim Chebli is a notable inventor based in Frontignan, France. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of inflammatory diseases. With two patents to his name, his work showcases the potential of quinoline derivatives in therapeutic applications.
Latest Patents
Karim Chebli's latest patents focus on the use of quinoline derivatives for the treatment of inflammatory diseases. The first patent discloses a compound of formula (I) or its pharmaceutically acceptable salts, aimed at treating and preventing inflammatory diseases. The second patent also relates to a compound of formula (I), emphasizing its application in the same therapeutic area. Both patents highlight the innovative use of chemical compounds to address significant health challenges.
Career Highlights
Throughout his career, Karim Chebli has worked with prominent organizations such as Abivax and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to develop and refine his research in medicinal chemistry, contributing to advancements in the treatment of inflammatory conditions.
Collaborations
Karim has collaborated with notable colleagues, including Jamal Tazi and Romain Najman. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapeutic solutions.
Conclusion
Karim Chebli's work exemplifies the intersection of innovation and healthcare, particularly in the realm of inflammatory disease treatment. His contributions through patents and collaborations continue to pave the way for future advancements in medicinal chemistry.